Genmab A-S

GMAB • NASDAQ •
Overview Stats Financials News

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range $26.32-$42.72
Market Cap $19.3B
Shares Short 2M

Financials

See more
Revenue (12 Mos) $17.7B
Revenue Growth (YoY) 45.2%
Gross Profit (12 Mos) $14.5B
Diluted EPS $1.21

News

See more

Yahoo Finance • 21 days ago

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

Yahoo Finance • 21 days ago

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Yahoo Finance • 2 months ago

30 Biggest Biotechnology Companies in the World

Yahoo Finance • 3 months ago

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma

About

CEO Dr. Jan G.J. van de Winkel Ph.D.
CFO Mr. Anthony Pagano
Address Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500
Sector Healthcare
Industry Biotechnology
Full-Time Employees 2,286